Sareum is a United Kingdom-based biotechnology company focused on the research and development of small-molecule therapeutics. Its pipeline has targeted autoimmune diseases and cancer through preclinical and early-stage drug development programs.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!